Efficacy of triclosan as an antimicrobial hand soap and its potential impact on antimicrobial resistance: A focused review

Pharmacotherapy

Volumn 35, Issue 3, 2015, Pages 328-336

  Giuliano, Christopher A ^a   Rybak, Michael J ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

antimicrobial soap; bacterial resistance; biocide; triclosan

Indexed keywords

2 PROPANOL; CHLORHEXIDINE; SOAP; TEA TREE OIL; TRICLOSAN; TOPICAL ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; BACTERICIDAL ACTIVITY; CAMPYLOBACTER; COMPARATIVE EFFECTIVENESS; CROSS RESISTANCE; DRUG EFFICACY; DRUG EXPOSURE; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; HAND WASHING; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PSEUDOMONAS AERUGINOSA; REVIEW; SALMONELLA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; DRUG EFFECTS; ENVIRONMENTAL EXPOSURE; HAND; MICROBIOLOGY; TREATMENT OUTCOME;

ANTI-INFECTIVE AGENTS, LOCAL; DRUG RESISTANCE, MICROBIAL; ENVIRONMENTAL EXPOSURE; HAND; HUMANS; SOAPS; TREATMENT OUTCOME; TRICLOSAN;

EID: 84925442143     PISSN: 02770008     EISSN: 18759114     Source Type: Journal    
DOI: 10.1002/phar.1553     Document Type: Review

References (58)

1. Scientific Committee on Consumer Safety. Opinion on Triclosan, June 2010. Available from http://ec.europa.eu/health/scientific-committees/consumer-safety/docs/sccs-o-023.pdf. Accessed April 5, 2014.
2. Adolfsson-Erici M, Pettersson M, Parkkonen J, Sturve J,. Triclosan, a commonly used bactericide found in human milk and in the aquatic environment in Sweden. Chemosphere 2002; 46: 1485-9.
3. Aiello AE, Larson EL, Levy SB,. Consumer antibacterial soaps: effective or just risky? Clin Infect Dis 2007; 45 (Suppl 2): S137-47.
4. USPTO Patent and Full-Text and Image Database, June 2014. Available from http://patft.uspto.gov/netahtml/PTO/search-bool.html. Accessed June 25, 2014.
5. Perencevich EN, Wong MT, Harris AD,. National and regional assessment of the antibacterial soap market: a step toward determining the impact of prevalent antibacterial soaps. Am J Infect Control 2001; 29: 281-3.
6. Food and Drug Administration. FDA Taking Closer Look at "Antibacterial" Soap, December 2013. Available from http://www.fda.gov/forconsumers/consumerupdates/ucm378393.htm. Accessed April 5, 2014.
7. Procter and Gamble. Tricosan. Available from http://www.pg.com/en-US/sustainability/safety/ingredients/triclosan.shtml. Accessed June 25, 2014.
8. Johnson & Johnson. Triclosan. Available from http://www.safetyandcarecommitment.com/ingredient-info/other/triclosan. Accessed June 25, 2014.
9. Environment Canada. Triclosan Preliminary Assessment, March 2012. Available from http://www.ec.gc.ca/ese-ees/default.asp?lang=En&n=6EF68BEC-1. Accessed June 25, 2014.
10. Dann AB, Hontela A,. Triclosan: environmental exposure, toxicity and mechanisms of action. J Appl Toxicol 2011; 31: 285-311.
11. Cahill JD, Furlong ET, Burkhardt MR, Kolpin D, Anderson LG,. Determination of pharmaceutical compounds in surface- and ground-water samples by solid-phase extraction and high-performance liquid chromatography-electrospray ionization mass spectrometry. J Chromatogr A 2004; 1041: 171-80.
12. Blair BD, Crago JP, Hedman CJ, Klaper RD,. Pharmaceuticals and personal care products found in the Great Lakes above concentrations of environmental concern. Chemosphere 2013; 93: 2116-23.
13. Bedoux G, Roig B, Thomas O, Dupont V, Le Bot B,. Occurrence and toxicity of antimicrobial triclosan and by-products in the environment. Environ Sci Pollut Res Int 2012; 19: 1044-65.
14. Wu X, Ernst F, Conkle JL, Gan J,. Comparative uptake and translocation of pharmaceutical and personal care products (PPCPs) by common vegetables. Environ Int 2013; 60: 15-22.
15. Sandborgh-Englund G, Adolfsson-Erici M, Odham G, Ekstrand J,. Pharmacokinetics of triclosan following oral ingestion in humans. J Toxicol Environ Health A 2006; 69: 1861-73.
16. Calafat AM, Ye X, Wong LY, Reidy JA, Needham LL,. Urinary concentrations of triclosan in the U.S. population: 2003-2004. Environ Health Perspect 2008; 116: 303-7.
17. Allmyr M, Harden F, Toms LM, et al. The influence of age and gender on triclosan concentrations in Australian human blood serum. Sci Total Environ 2008; 393: 162-7.
18. Allmyr M, Adolfsson-Erici M, McLachlan MS, Sandborgh-Englund G,. Triclosan in plasma and milk from Swedish nursing mothers and their exposure via personal care products. Sci Total Environ 2006; 372: 87-93.
19. Kampf G, Kramer A,. Epidemiologic background of hand hygiene and evaluation of the most important agents for scrubs and rubs. Clin Microbiol Rev 2004; 17: 863-93, table of contents.
20. Yazdankhah SP, Scheie AA, Hoiby EA, et al. Triclosan and antimicrobial resistance in bacteria: an overview. Microb Drug Resist 2006; 12: 83-90.
21. Bartzokas CA, Corkill JE, Makin T,. Evaluation of the skin disinfecting activity and cumulative effect of chlorhexidine and triclosan handwash preparations on hands artificially contaminated with Serratia marcescens. Infect Control 1987; 8: 163-7.
22. Bendig JW,. Surgical hand disinfection: comparison of 4% chlorhexidine detergent solution and 2% triclosan detergent solution. J Hosp Infect 1990; 15: 143-8.
23. Leyden JJ, McGinley KJ, Kaminer MS, et al. Computerized image analysis of full-hand touch plates: a method for quantification of surface bacteria on hands and the effect of antimicrobial agents. J Hosp Infect 1991; 18 (Suppl B): 13-22.
24. Fuls JL, Rodgers ND, Fischler GE, et al. Alternative hand contamination technique to compare the activities of antimicrobial and nonantimicrobial soaps under different test conditions. Appl Environ Microbiol 2008; 74: 3739-44.
25. Quraishi ZA, McGuckin M, Blais FX,. Duration of handwashing in intensive care units: a descriptive study. Am J Infect Control 1984; 12: 83-7.
26. Gnatta JR, Pinto FM, Bruna CQ, Souza RQ, Graziano KU, Silva MJ,. Comparison of hand hygiene antimicrobial efficacy: Melaleuca alternifolia essential oil versus triclosan. Rev Lat Am Enfermagem 2013; 21: 1212-9.
27. Sickbert-Bennett EE, Weber DJ, Gergen-Teague MF, Sobsey MD, Samsa GP, Rutala WA,. Comparative efficacy of hand hygiene agents in the reduction of bacteria and viruses. Am J Infect Control 2005; 33: 67-77.
28. Geraldo IM, Gilman A, Shintre MS, Modak SM,. Rapid antibacterial activity of 2 novel hand soaps: evaluation of the risk of development of bacterial resistance to the antibacterial agents. Infect Control Hosp Epidemiol 2008; 29: 736-41.
29. Larson EL, Lin SX, Gomez-Pichardo C, Della-Latta P,. Effect of antibacterial home cleaning and handwashing products on infectious disease symptoms: a randomized, double-blind trial. Ann Intern Med 2004; 140: 321-9.
30. Zafar AB, Butler RC, Reese DJ, Gaydos LA, Mennonna PA,. Use of 0.3% triclosan (Bacti-Stat) to eradicate an outbreak of methicillin-resistant Staphylococcus aureus in a neonatal nursery. Am J Infect Control 1995; 23: 200-8.
31. Rashid A, Solomon LK, Lewis HG, Khan K,. Outbreak of epidemic methicillin-resistant Staphylococcus aureus in a regional burns unit: management and implications. Burns 2006; 32: 452-7.
32. Lanini S, D'Arezzo S, Puro V, et al. Molecular epidemiology of a Pseudomonas aeruginosa hospital outbreak driven by a contaminated disinfectant-soap dispenser. PLoS ONE 2011; 6: e17064.
33. Barry MA, Craven DE, Goularte TA, Lichtenberg DA,. Serratia marcescens contamination of antiseptic soap containing triclosan: implications for nosocomial infection. Infect Control 1984; 5: 427-30.
34. Edmonds SL, Zapka C, Kasper D, et al. Effectiveness of hand hygiene for removal of Clostridium difficile spores from hands. Infect Control Hosp Epidemiol 2013; 34: 302-5.
35. McMurry LM, Oethinger M, Levy SB,. Triclosan targets lipid synthesis. Nature 1998; 394: 531-2.
36. Yu BJ, Kim JA, Pan JG,. Signature gene expression profile of triclosan-resistant Escherichia coli. J Antimicrob Chemother 2010; 65: 1171-7.
37. Cottell A, Denyer SP, Hanlon GW, Ochs D, Maillard JY,. Triclosan-tolerant bacteria: changes in susceptibility to antibiotics. J Hosp Infect 2009; 72: 71-6.
38. Braoudaki M, Hilton AC,. Adaptive resistance to biocides in Salmonella enterica and Escherichia coli O157 and cross-resistance to antimicrobial agents. J Clin Microbiol 2004; 42: 73-8.
39. Zhu L, Lin J, Ma J, Cronan JE, Wang H,. Triclosan resistance of Pseudomonas aeruginosa PAO1 is due to FabV, a triclosan-resistant enoyl-acyl carrier protein reductase. Antimicrob Agents Chemother 2010; 54: 689-98.
40. Cookson BD, Farrelly H, Stapleton P, Garvey RP, Price MR,. Transferable resistance to triclosan in MRSA. Lancet 1991; 337: 1548-9.
41. Suller MT, Russell AD,. Triclosan and antibiotic resistance in Staphylococcus aureus. J Antimicrob Chemother 2000; 46: 11-8.
42. Bamber AI, Neal TJ,. An assessment of triclosan susceptibility in methicillin-resistant and methicillin-sensitive Staphylococcus aureus. J Hosp Infect 1999; 41: 107-9.
43. Ciusa ML, Furi L, Knight D, et al. A novel resistance mechanism to triclosan that suggests horizontal gene transfer and demonstrates a potential selective pressure for reduced biocide susceptibility in clinical strains of Staphylococcus aureus. Int J Antimicrob Agents 2012; 40: 210-20.
44. Bayston R, Ashraf W, Smith T,. Triclosan resistance in methicillin-resistant Staphylococcus aureus expressed as small colony variants: a novel mode of evasion of susceptibility to antiseptics. J Antimicrob Chemother 2007; 59: 848-53.
45. Skovgaard S, Nielsen LN, Larsen MH, Skov RL, Ingmer H, Westh H,. Staphylococcus epidermidis isolated in 1965 are more susceptible to triclosan than current isolates. PLoS ONE 2013; 8: e62197.
46. Schmid MB, Kaplan N,. Reduced triclosan susceptibility in methicillin-resistant Staphylococcus epidermidis. Antimicrob Agents Chemother 2004; 48: 1397-9.
47. Randall LP, Cooles SW, Piddock LJ, Woodward MJ,. Effect of triclosan or a phenolic farm disinfectant on the selection of antibiotic-resistant Salmonella enterica. J Antimicrob Chemother 2004; 54: 621-7.
48. Copitch JL, Whitehead RN, Webber MA,. Prevalence of decreased susceptibility to triclosan in Salmonella enterica isolates from animals and humans and association with multiple drug resistance. Int J Antimicrob Agents 2010; 36: 247-51.
49. Helms M, Vastrup P, Gerner-Smidt P, Molbak K,. Excess mortality associated with antimicrobial drug-resistant Salmonella typhimurium. Emerg Infect Dis 2002; 8: 490-5.
50. Chen Y, Pi B, Zhou H, Yu Y, Li L,. Triclosan resistance in clinical isolates of Acinetobacter baumannii. J Med Microbiol 2009; 58: 1086-91.
51. Su XZ, Chen J, Mizushima T, Kuroda T, Tsuchiya T,. AbeM, an H+-coupled Acinetobacter baumannii multidrug efflux pump belonging to the MATE family of transporters. Antimicrob Agents Chemother 2005; 49: 4362-4.
52. Mavri A, Smole Mozina S,. Development of antimicrobial resistance in Campylobacter jejuni and Campylobacter coli adapted to biocides. Int J Food Microbiol 2013; 160: 304-12.
53. Randall LP, Ridley AM, Cooles SW, et al. Prevalence of multiple antibiotic resistance in 443 Campylobacter spp. isolated from humans and animals. J Antimicrob Chemother 2003; 52: 507-10.
54. Cullinan MP, Bird PS, Heng NC, West MJ, Seymour GJ,. No evidence of triclosan-resistant bacteria following long-term use of triclosan-containing toothpaste. J Periodontal Res 2014; 49: 220-5.
55. McMurry LM, McDermott PF, Levy SB,. Genetic evidence that InhA of Mycobacterium smegmatis is a target for triclosan. Antimicrob Agents Chemother 1999; 43: 711-3.
56. Freundlich JS, Wang F, Vilcheze C, et al. Triclosan derivatives: towards potent inhibitors of drug-sensitive and drug-resistant Mycobacterium tuberculosis. ChemMedChem 2009; 4: 241-8.
57. Valenzuela AS, Benomar N, Abriouel H, Canamero MM, Lopez RL, Galvez A,. Biocide and copper tolerance in enterococci from different sources. J Food Prot 2013; 76: 1806-9.
58. Beier RC, Duke SE, Ziprin RL, et al. Antibiotic and disinfectant susceptibility profiles of vancomycin-resistant Enterococcus faecium (VRE) isolated from community wastewater in Texas. Bull Environ Contam Toxicol 2008; 80: 188-94.